Thymopentin compared with levamisole and penicillamine in rheumatoid arthritis
Randomized study in people · 1982
- What was studied
- 36 adults with active rheumatoid arthritis at St Bartholomew’s Hospital in London, 12 assigned to each of three treatment groups.
- Main finding
- Six-month pain score reduction · 7.67 points with thymopentin, 2.92 with levamisole and 5.00 with penicillamine. Thymopentin differed from levamisole (p<0.05).
Reported findings and study design
Reported findings
Randomized six-month comparison of thymopentin 50 mg IV once weekly, levamisole 150 mg orally once weekly, or penicillamine 250–750 mg orally daily. The clinical assessor was masked and patients knew their treatment. Existing anti-inflammatory therapy continued. Eleven thymopentin recipients subsequently crossed to levamisole.
Population or model 36 adults with active rheumatoid arthritis at St Bartholomew’s Hospital in London, 12 assigned to each of three treatment groups.
Dose, route and schedule
Randomized six-month comparison of thymopentin 50 mg IV once weekly, levamisole 150 mg orally once weekly, or penicillamine 250–750 mg orally daily. The clinical assessor was masked and patients knew their treatment. Existing anti-inflammatory therapy continued. Eleven thymopentin recipients subsequently crossed to levamisole.
Protocol source ↗ · Original full-text scan, methods and Tables II–V.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Six-month pain score reduction | 7.67 points with thymopentin, 2.92 with levamisole and 5.00 with penicillamine. Thymopentin differed from levamisole (p<0.05). | |
| Other clinical outcomes | No other clinical comparison with levamisole or penicillamine reached statistical significance. Thymopentin’s mean ESR fell by 9.75 mm/h (0.05<p<0.10). | |
| Adverse events in the thymopentin arm | Two rashes and one mild herpes zoster case. One rash worsened after successive injections and resolved after treatment stopped. |
Six-month mean reductions, with standard errors
| Measure | Thymopentin (n=12) | Levamisole (n=12) | Penicillamine (n=12) |
|---|---|---|---|
| Pain score | 7.67 ± 1.38 | 2.92 ± 1.68 | 5.00 ± 1.38 |
| Morning stiffness, min | 68.75 ± 20.95 | 28.75 ± 15.19 | 29.25 ± 11.85 |
| Articular index | 8.00 ± 1.72 | 5.25 ± 1.51 | 4.58 ± 0.80 |
With 12 per arm and patients aware of assignment, the pain result is vulnerable to expectation effects. The study did not establish equivalence to penicillamine. Three authors and the London center also appear in Veys’s 1982 paper, so participant overlap cannot be ruled out.
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- With 12 per arm and patients aware of assignment, the pain result is vulnerable to expectation effects. The study did not establish equivalence to penicillamine. Three authors and the London center also appear in Veys’s 1982 paper, so participant overlap cannot be ruled out.
Source details
Original full-text scan, methods and Tables II–V.
Sources checked
Added to the library
Citation
P. A. Thrower, D. V. Doyle, J. Scott, E. C. Huskisson. Thymopentin compared with levamisole and penicillamine in rheumatoid arthritis Rheumatology and Rehabilitation 21(2), 72–77
Study source ↗ · DOI 10.1093/rheumatology/21.2.72 · Bibliography entry · Link to this summary